NFE2L2 and cancer: In addition, NFE2L2 was a protective factor in 3 other types of cancer: KIRC (P < 0.0001, HR = 0.99), MESO (P = 0.0022, HR = 0.99), and SARC (P = 0.0033, HR = 0.99) (Figures 3(b)–3(h)).